Clearside Biomedical Cash from Operations (TTM) Insights

Clearside Biomedical Inc (CLSD)

1.34 +0.08 (+6.35%) USD | NASDAQ | Apr 26, 16:00

1.30 -0.04 (-2.99%) Pre-Market: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-18.14M
September 30, 2023	-24.24M
June 30, 2023	-24.35M
March 31, 2023	-24.45M
December 31, 2022	-13.36M
September 30, 2022	-2.704M
June 30, 2022	0.204M
March 31, 2022	-1.303M
December 31, 2021	-10.73M
September 30, 2021	-20.22M
June 30, 2021	-19.61M
March 31, 2021	-15.88M
December 31, 2020	-13.12M
September 30, 2020	-6.995M
June 30, 2020	-10.38M
March 31, 2020	-17.22M
December 31, 2019	-27.07M

Date	Value
September 30, 2019	-53.02M
June 30, 2019	-66.69M
March 31, 2019	-76.20M
December 31, 2018	-79.20M
September 30, 2018	-70.03M
June 30, 2018	-63.78M
March 31, 2018	-55.76M
December 31, 2017	-51.08M
September 30, 2017	-42.45M
June 30, 2017	-35.36M
March 31, 2017	-29.29M
December 31, 2016	-22.71M
September 30, 2016	-20.08M
June 30, 2016	-16.86M
March 31, 2016	-14.55M
December 31, 2015	-13.90M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-66.69M

Minimum

Jun 2019

0.204M

Maximum

Jun 2022

-19.43M

Average

-17.22M

Median

Mar 2020

Cash from Operations (TTM) Benchmarks